Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
RetroVirox
company
About
RetroVirox is a privately-held biotechnology company dedicated to discovering new treatments for patients with infectious diseases
- 1 - 10
Highlights
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $3M
- Industries
- Biotechnology,Health Care,Health Diagnostics,Innovation Management,Life Science
- Founded date
- Jan 1, 2008
- Number Of Employee
- 1 - 10
- Operating Status
- Active
RetroVirox is an innovative, privately-held biotechnology company dedicated to discovering new treatments for patients with infectious disease.RetroVirox offers its expertise in antiviral assays and cell-based screening for antiviral compounds to other biotechnology and pharmaceutical companies.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$3M
RetroVirox has raised a total of
$3M
in funding over 2 rounds. Their latest funding was raised on
Mar 12, 2015 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 12, 2015 | Grant | $3M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
RetroVirox is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
